Powered by: Motilal Oswal
2025-12-18 11:45:36 am | Source: Accord Fintech
Fabtech Technologies gains on getting nod to incorporate wholly owned subsidiary in UAE
Fabtech Technologies gains on getting nod to incorporate wholly owned subsidiary in UAE

Fabtech Technologies Cleanrooms is currently trading at Rs 302.60, up by 0.60 points or 0.20% from its previous closing of Rs. 302.60 on the BSE.

The scrip opened at Rs. 302.00 and has touched a high and low of Rs. 306.00 and Rs. 301.95 respectively. So far 95600 shares were traded on the counter.

The BSE group 'M' stock of face value Rs. 10 has touched a 52 week high of Rs. 470.00 on 21-Jul-2025 and a 52 week low of Rs. 161.50 on 10-Jan-2025.

Last one week high and low of the scrip stood at Rs. 325.00 and Rs. 301.95 respectively. The current market cap of the company is Rs. 372.78 crore.

The promoters holding in the company stood at 68.49%, while Institutions and Non-Institutions held 8.97% and 22.54% respectively.

Fabtech Technologies Cleanrooms has received approval for the incorporation of foreign wholly owned subsidiary company in the name and style ‘Fabtech Technologies Cleanrooms-FZE’ or any other appropriate name as may be approved by the Authority. The proposed subsidiary is to be incorporated in United Arab Emirates (UAE) and it will belong to manufacturing/ trading of pharmaceutical cleanrooms industry.

The proposed subsidiary company will be incorporated with an objective to carry on the business as turnkey projects solution provider, manufacturer of pharmaceutical machineries, sterlite, LAF, modular, clean room & equipment, chemical equipment, etc. The board of directors of the company at their meeting held on December 17, 2025 have inter alia, considered and approved the same.

Fabtech Technologies Cleanrooms is engaged in the business of manufacturing pre-engineered, pre-fabricated modular panels and doors for building internal infrastructure for pharmaceuticals and allied industries.

 

 

Disclaimer: The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references. To Read Complete Disclaimer Click Here